These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 20422824)

  • 1. Evaluation of quality of life for patients with schizophrenic and schizoaffective disorders related to the use of antipsychotic therapy.
    Golubovic B; Misic-Pavkov G; Gajic Z; Ivanovic-Kovacevic S
    Med Arh; 2010; 64(1):37-40. PubMed ID: 20422824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcome of schizoaffective disorder. Are there any differences with respect to schizophrenia?
    Pinna F; Sanna L; Perra V; Pisu Randaccio R; Diana E; Carpiniello B;
    Riv Psichiatr; 2014; 49(1):41-9. PubMed ID: 24572583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia.
    Wehmeier PM; Kluge M; Schneider E; Schacht A; Wagner T; Schreiber W
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):703-12. PubMed ID: 17289237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients.
    Popović I; Ravanić D; Popović V; Vladejić S; Stanojević A; Stojanović M
    Psychiatr Danub; 2011 Dec; 23(4):384-8. PubMed ID: 22075740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aripiprazole in schizophrenia and schizoaffective disorder: A review.
    Stip E; Tourjman V
    Clin Ther; 2010; 32 Suppl 1():S3-20. PubMed ID: 20152550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The retinoid X receptor agonist bexarotene relieves positive symptoms of schizophrenia: a 6-week, randomized, double-blind, placebo-controlled multicenter trial.
    Lerner V; Miodownik C; Gibel A; Sirota P; Bush I; Elliot H; Benatov R; Ritsner MS
    J Clin Psychiatry; 2013 Dec; 74(12):1224-32. PubMed ID: 24434091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients in the early phases of schizophrenia and schizoaffective disorders effectively treated with risperidone long-acting injectable.
    Parellada E; Andrezina R; Milanova V; Glue P; Masiak M; Turner MS; Medori R; Gaebel W
    J Psychopharmacol; 2005 Sep; 19(5 Suppl):5-14. PubMed ID: 16144781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Choosing antipsychotic maintenance therapy--a naturalistic study.
    Tavcar R; Dernovsek MZ; Zvan V
    Pharmacopsychiatry; 2000 Mar; 33(2):66-71. PubMed ID: 10761822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses.
    Turner MS; Stewart DW
    J Psychopharmacol; 2006 Nov; 20(6 Suppl):20-37. PubMed ID: 17046985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypofrontality in schizophrenic patients and its relevance for the choice of antipsychotic medication: an event-related potential study.
    Ehlis AC; Pauli P; Herrmann MJ; Plichta MM; Zielasek J; Pfuhlmann B; Stöber G; Ringel T; Jabs B; Fallgatter AJ
    World J Biol Psychiatry; 2012 Mar; 13(3):188-99. PubMed ID: 21517702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation between subjective well-being and pharmacological therapy in patients with psychotic disorders].
    Antonini V; Corradi A; Buizza C; Vittorielli M; Pioli R; Rossi G
    Recenti Prog Med; 2004 Dec; 95(12):581-4. PubMed ID: 15666490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms: a randomized double-blind multicenter trial.
    Möller HJ; Riedel M; Müller N; Fischer W; Kohnen R
    Pharmacopsychiatry; 2004 Nov; 37(6):270-8. PubMed ID: 15551193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Quality of life of patient with schizophrenia treated by conventional and atypical neuroleptics].
    Zaghdoudi L; Homri W; Belaid S; Ben Bechir M; Labbane R
    Tunis Med; 2009 Sep; 87(9):593-8. PubMed ID: 20180380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of novel and conventional antipsychotic medication on subjective quality of life.
    Tempier R; Pawliuk N
    J Psychiatry Neurosci; 2001 Mar; 26(2):131-6. PubMed ID: 11291530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective, open-label study to evaluate symptomatic remission in schizophrenia with risperidone long-acting injectable in Korea.
    Lee NY; Kim SH; Cho SJ; Chung YC; Jung IK; Kim CY; Kim DH; Lee DG; Lee YH; Lim WJ; Na YS; Shin SE; Woo JM; Yoon JS; Yoon BH; Ahn YM; Kim YS
    Int Clin Psychopharmacol; 2014 Sep; 29(5):279-87. PubMed ID: 24583566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term efficacy and safety of aripiprazole in patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder: 26-week prospective study.
    Kwon JS; Jang JH; Kang DH; Yoo SY; Kim YK; Cho SJ;
    Psychiatry Clin Neurosci; 2009 Feb; 63(1):73-81. PubMed ID: 19154213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A controlled, mirror-image study of second-generation antipsychotics in the treatment of schizophrenia.
    Taylor D; Hayhurst K; Kerwin R
    Int Clin Psychopharmacol; 2007 May; 22(3):133-6. PubMed ID: 17414738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adverse effects of antipsychotics and quality of life].
    Mínguez Martín L; González Pablos E; Alonso del Teso F; Sanguino Andrés RM; García Alonso Y
    Actas Esp Psiquiatr; 2005; 33(1):1-6. PubMed ID: 15704024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.